People: Transition Therapeutics Inc (TTH.TO)
Ms. Nicole Rusaw, C.A., is Chief Financial Officer of Transition Therapeutics Inc. Ms. Rusaw has been with the Company since 2005 and was appointed as Chief Financial Officer in December 2011. While at Transition, Ms. Rusaw has been responsible for a broad range of activities with a focus on financial reporting and regulatory compliance as well as involvement in various equity financings and strategic acquisitions.
|Total Annual Compensation, CAD||222,480|
|Restricted Stock Awards, CAD||--|
|Long-Term Incentive Plans, CAD||--|
|All Other, CAD||93,574|
|Fiscal Year Total, CAD||316,054|